Nine Chapters Capital Management’s United Therapeutics UTHR Stock Holding History

Nine Chapters Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$352K	Buy	+3,000	New	+$383K	0.78%	52
2017 Q1	–	Sell	-1,600	Closed	-$229K	–	306
2016 Q4	$229K	Buy	+1,600	New	+$204K	0.39%	97
2015 Q3	–	Sell	-16,700	Closed	-$2.9M	–	1184
2015 Q2	$2.9M	Buy	+16,700	New	+$3M	0.24%	97
2015 Q1	–	Sell	-6,000	Closed	-$777K	–	1138
2014 Q4	$777K	Buy	+6,000	New	+$773K	0.07%	404
2014 Q3	–	Sell	-23,800	Closed	-$2.11M	–	1177
2014 Q2	$2.11M	Buy	+23,800	New	+$2.29M	0.17%	163

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Nine Chapters Capital Management's UTHR Position: Q3 2017 in Review

Nine Chapters Capital Management opened a new position in United Therapeutics (UTHR) in Q3 2017: 3,000 shares worth $352K. The stake represents 0.78% of the portfolio and ranks #52 among its holdings. This is a return to the name: Nine Chapters Capital Management previously reported a position in UTHR as recently as Q4 2016.

Nine Chapters Capital Management first reported a position in UTHR in Q2 2014 and has held it in 5 quarters since. The position peaked at $2.9M in Q2 2015. 373 funds tracked by Wall St. Rank hold UTHR as of Q3 2017.

Nine Chapters Capital Management held 3,000 shares of United Therapeutics worth $352K as of Q3 2017.
United Therapeutics was a new Nine Chapters Capital Management position in Q3 2017.
United Therapeutics made up 0.78% of Nine Chapters Capital Management's portfolio in Q3 2017, its #52 holding.
Nine Chapters Capital Management first reported a position in United Therapeutics in Q2 2014 and has held it in 5 quarters since.
Nine Chapters Capital Management's United Therapeutics position peaked at $2.9M in Q2 2015.
373 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2017.

Based on Nine Chapters Capital Management's 13F filing for Q3 2017, filed 31 Oct 2017.